1 0

    FDA Summary Basis of Approval for NDA 020472 – ESTRING (Estradiol Vaginal System)

    FDA Summary Basis of Approval for NDA 020472 – ESTRING (Estradiol Vaginal System)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Summary Basis of Approval (SBOA) for NDA 020472 Proprietary Name: ESTRING (estradiol vaginal system). Strength: 0.0075MG/24HR. Approval Date: Apr. 26, 1996. Held by: Pfizer, Inc.
    Tags: Pharma, NDA, 1996
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details